For healthcare, public health & education professionals

Confident conversations about the HPV vaccination

A practical toolkit to help you answer questions, address concerns and have constructive conversations with parents and young people — built on evidence and real workshop experience.

280M+doses given worldwide
~20 yrsof real-world evidence
2040UK target to eliminate cervical cancer

A UCL Disagreeing Well project, developed with Vaccination UK

About this toolkit

Supporting better vaccine conversations

This toolkit is designed to support professionals working in healthcare, public health, and education — including public health professionals, vaccine nurses, GPs, and researchers and education staff — in having confident, constructive conversations with parents and young people about HPV vaccination.

Developed with practitioners

Created through a project funded by the UCL Disagreeing Well programme, bringing together public health professionals, vaccine nurses, GPs and researchers in a workshop with parents and education staff.

Evidence-based answers

Clear responses to common questions and myths, each linked to trusted sources such as the WHO, UKHSA, NHS, the CDC and peer-reviewed research, so you can dig deeper with confidence.

Real conversation skills

Techniques for listening with empathy, finding common ground and responding to hesitancy — drawn from workshop experience and the Disagreeing Well approach.

This digital version includes links to further guidance, training materials and practical resources throughout. Every underlined link opens a trusted external source in a new tab.

The essentials

Frequently asked questions

Straightforward answers to the questions parents and young people ask most often. Tap any question to expand it.

HPV (Human Papillomavirus) causes almost all of the main types of cervical cancer, as well as other genital and head and neck cancers. Two types of HPV, HPV 16 and HPV 18, cause about 70% of all cervical cancer cases.

However, most cervical cancers can be prevented by having the HPV vaccination and regular cervical screening from age 25.

HPV is spread through skin-to-skin contact with someone who has the virus, usually through intimate contact.

The HPV vaccination is given as an injection in the upper arm.

Vaccines teach your immune system how to create antibodies that protect you from diseases. Once your immune system knows how to fight HPV, it can give you up to lifelong protection.

The Gardasil 9 vaccine (the type used in the UK) protects against 9 high-risk HPV types. It does not contain a live virus, so it cannot cause HPV infection — it will only protect you against infection.

The HPV vaccine is very safe for children. Common side effects are usually mild and temporary. The most common are having a sore or red arm, or slight swelling where the shot was given — up to 1 in 10 people can experience these. Less commonly, people can experience mild fever, nausea or headache. All of these can easily be treated at home with paracetamol.

Serious side effects are extremely rare (1.7 cases per 1 million doses according to the World Health Organization), and the benefits of protection against HPV-related cancers far outweigh these mild reactions.

Two scenes: on the day of vaccination a teenager rests on the sofa with a plaster on their arm while a parent brings a drink — ‘it’s ok, side effects are normal’ — and the next day the same teenager is back outside playing with the dog.
Any side effects are usually mild and short-lived — often gone within a day or two.

Landmark new research reveals that children vaccinated at age 12–13 against HPV have close to zero risk of dying from cervical cancer before the age of 30. People can read about this on reputable news sources like BBC News and The Guardian, or go to the original study for even more detail. This study was published in The Lancet, one of the world’s most respected medical journals, so research published there has been checked by leading experts and is considered highly reliable.

The HPV vaccine is also effective at reducing other cancers, such as head and neck cancers, which can affect both men and women — the vaccine is 88–93% effective at preventing oral HPV infection, according to a review combining data from six studies.

For more studies demonstrating HPV vaccine effectiveness, see data from multiple countries listed by GAVI (the Global Alliance for Vaccines and Immunisation) and recent reviews combining evidence from multiple studies.

Cervical cancer elimination. The UK government has pledged to eliminate cervical cancer as a public health problem by 2040. In the 2023–2024 academic year, 77% of girls and 71% of boys aged 14–15 had been vaccinated — well below the 90% that the World Health Organization (WHO) says is needed to eliminate cervical cancer. Coverage needs to increase.

HPV elimination. Vaccination doesn’t just protect individuals — when enough people are vaccinated, the virus has far fewer chances to spread, even to those who aren’t vaccinated. This community-wide protection is called herd immunity. As herd immunity grows, HPV circulation drops so low that the virus may eventually disappear altogether.

Parental consent is usually sought for medical decisions for children under the age of 16. However, in some cases — where the child may want the vaccine but the parent has not provided consent — the child can be assessed for Gillick competence. A healthcare professional can assess whether the young person can demonstrate sufficient understanding to make an informed decision, and can consent to (or decline) the vaccine. This means that a parent’s consent does not automatically override a young person’s clearly expressed refusal, and vice versa.

The assessment will consider whether the young person understands what the vaccine is, why it’s offered, and the potential consequences of accepting or declining — as well as whether they are making the decision freely, without pressure from others.

How this is applied varies across schools and immunisation teams in the UK, so if you’re unsure of the policy in your area, it’s worth checking with your local immunisation team.

Gillick competence doesn’t just refer to consent for vaccination, but to a range of medical decisions, such as use of contraception and general medical care.

Read more about Gillick competence here, and in our Conversations with Kids section.

Setting the record straight

Myth-busting

Common myths about the HPV vaccine — and the evidence that addresses them. Each card opens with the claim you might hear, followed by the facts.

The facts

The vaccine is most effective when given before exposure to HPV, which is why it is offered during the school years. In fact, some countries offer the HPV vaccine at the age of 9, in primary school. The earlier you vaccinate, the better the immune response and the stronger the protection.

Find further information here.

The facts

The HPV vaccine used to be offered to girls only, but HPV can affect anyone. The vaccine protects all genders against cervical cancer, cancers of the head and neck, genital cancers and genital warts. Vaccinating everyone boosts individual and community protection. In the UK, it’s been offered to girls since 2008 and boys since 2019.

Find further information here.

The facts

The vaccine is not live, and doesn’t contain the HPV virus, meaning that your child will not become infected with HPV.

Some other vaccines do contain live viruses, but these are weakened versions of the virus and are also very safe. Find further information on the different types of vaccine, and Vaccination UK has a great video explaining how the HPV vaccine works.

The facts

There is no evidence of this. A large study found no increased risk for people who had the HPV vaccine. The HPV vaccine can actually help protect fertility by preventing gynaecological problems related to the treatment of cervical cancer.

The facts

Over 280 million doses of the HPV vaccine have been given worldwide, including 120 million doses in the US and over 10 million in the UK.

With nearly 20 years of real-world evidence (so not just in clinical trials) and endorsement from WHO and CDC, it is one of the most thoroughly studied vaccines in existence. The national HPV vaccination programme was introduced in the UK in 2008 — nearly 20 years ago.

The facts

HPV is really common — 4 out of 5 people will get HPV at some point during their life, if there is no vaccination programme. (However, as more people get vaccinated, HPV becomes less common — see info on elimination.)

A crowd of young people at a school disco, most shown in purple and a few in green, illustrating how common HPV is.
Picture a school disco: without vaccination, around 4 in 5 of these young people (shown in purple) would catch HPV at some point in their lives — only the few in green would avoid it.
The facts

An extensive World Health Organization expert review found that receiving several vaccines — even during the same visit — does not weaken or overload the immune system. Vaccines actually strengthen the immune system.

Your immune system deals with huge numbers of microbes and other challenges every day. It can easily cope with multiple vaccinations.

Find further information here.

The facts

No. HPV can spread through close skin-to-skin contact, so it isn’t only passed on through penetrative sex. Condoms reduce the risk but do not fully prevent infection.

The facts

The HPV vaccine stops HPV-related cancers from developing in the first place by preventing the infection that causes them.

Cervical cancer is the only cancer we currently have a screening test for — there are no routine screening tests for the other HPV-related cancers. HPV can cause five other types of cancer (vulvar, vaginal, anal, penile and oropharyngeal/head and neck cancers), and HPV-related cancers affect men as well as women. See more detail on HPV-related oropharyngeal (head and neck) cancers.

Screening helps find early changes or early cancer so they can be treated before they become serious. Cervical screening is only offered to women once they turn 25, so we need to ensure that young people, male and female, are still protected against HPV.

The facts

Vaccines undergo rigorous safety testing as part of the licensing process. The safety of HPV vaccines was tested in thousands of volunteers before the vaccines were approved. Since the HPV vaccine was licensed in 2006 it has been strictly monitored and frequently reviewed by many national and international bodies — for example the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK and the Centers for Disease Control and Prevention (CDC) in the US.

All international bodies have continually reported that HPV vaccines are safe with no known long-term side effects. The only known severe reaction is a severe allergic reaction, which occurs in about one in every million people given the vaccine. The benefits far outweigh the risks.

If people want to know more detail: Cochrane reviews are considered highly reliable because they bring together and rigorously analyse evidence from many high-quality studies, rather than relying on a single trial. By pooling data from large numbers of participants, these reviews provide a clearer, more precise picture of both the benefits and risks of HPV vaccination. They show strong, consistent findings that HPV vaccines prevent cervical cancer and precancerous changes, with only minor, short-lived side effects and no evidence of serious safety concerns.

The facts

The HPV vaccine used in the UK is Gardasil-9. This vaccine contains individual proteins from nine types of HPV virus, which produce an immune response. These are not live viruses and will not develop into an infection.

Apart from the active ingredients (the antigens), it contains tiny amounts of other ingredients which are important to make the vaccine effective and to preserve it as it is stored and transported.

Some people have expressed concern that the vaccine contains tiny amounts of aluminium salts, but the amounts are so small that, according to the US Food and Drug Administration (FDA), the most common source of aluminium exposure is food and drinking water, not vaccines. A 24-year-long study of more than 1.2 million Danish children found no link between aluminium in childhood vaccines and the development of any neurodevelopmental disorders, and no connection to autoimmune and allergic disorders.

See further information on Gardasil-9 ingredients here, and a useful explanation of why we need extra ingredients in vaccines here.

The facts

If your child missed the school vaccinations, they can get the HPV vaccination up until their 25th birthday through the NHS. This includes boys who became eligible from the 2019/2020 academic year. It is also offered to men aged 45 and under who have sex with men.

You can contact your GP or local school immunisation service to arrange a ‘catch-up’ vaccination.

In practice

Conversation scenarios

Hypothetical scenarios which emerged from our development workshop, based on the real experiences of the participants working with parents and children. Each comes with practical suggestions shared by that workshop of healthcare and education professionals and parents. (They cover a range of secondary school-age vaccinations.)

Infographic titled ‘Immunisations — growing up prepared and protected’, showing four stages: baby and pre-school, primary school, secondary school and healthy adulthood, with the vaccines and the everyday kit that belong to each.
HPV vaccine · concerns about sexual activity

“My child is too young to be thinking about this”

A Year 8 student (aged 12–13) is due to receive the HPV vaccine through the school immunisation programme. The parent hasn’t completed the consent form, so the team phones to follow up. They feel the information focuses too much on sexual activity and STIs.

“I’ve looked online and everything links the HPV vaccine to sexual activity. My child is only 12 and definitely not sexually active, so I don’t understand why they need this vaccine now.”

Comments from our workshop

A school pupil with a backpack walking towards a signpost reading ‘The Future’, kicking a football.
Vaccinating now is about protecting future health.
  • Take care not to cause offence.
  • Emphasise the aim of protecting young people rather than the details of sexual activity.
  • Frame the message around giving the vaccine before children are ever exposed to HPV, rather than talking about sexual activity. The vaccine works best before any exposure to the virus, which is why it’s offered at a young age — this helps parents think about protection, not sexual behaviour.
  • Children are immunised when they’re young, before they are exposed to HPV, which gives them the best protection.
  • Make it uncontroversial: “HPV vaccination is part of preparing them for growing up.”
  • Vaccination is for everyone — it is not judging people by what they do. Everyone deserves to be protected.
  • Most young people will become sexually active at some point in their lives. Vaccinating now is about protecting them for the future — it helps parents focus on doing the best for the adults their children will grow up to be.
  • Some vaccine nurses use euphemisms such as “intimate contact” or “skin-to-skin contact,” which may help with acceptability — though take care this isn’t misinterpreted as HPV passing through casual contact like holding hands.
  • Make a comparison with the DTP vaccine: we vaccinate everyone against polio even though they’re unlikely to be exposed here in the UK — we need protection “just in case.”
  • A point for children rather than parents: “Future partners may ask whether you’ve been vaccinated, and may feel safer if you are protected.”
Preference for “natural immunity”

“I’d rather my child built immunity naturally”

A secondary school student is offered the seasonal flu vaccine through the school immunisation programme. The parent has declined consent, believing children should build their immune systems naturally and that catching flu helps strengthen immunity.

“I don’t really agree with the flu vaccine. I believe in natural immunity — I never had it as a child.” “My child is healthy and hardly ever gets ill.” “I had flu before and recovered fine, so I don’t see why children need a vaccine every year.”

Comments from our workshop

  • Acknowledge the underlying belief respectfully: “Lots of parents value natural immunity — it’s completely understandable to want your child to be strong and healthy.” Directly contradicting it can feel confrontational; start by finding common ground.
  • Explain the difference between infection-acquired and vaccine-acquired immunity. Emphasise that vaccines train the immune system without the risks of the illness itself.
  • Use relatable, non-technical language. Avoid jargon; keep it simple and focused on what matters for their child.
  • Acknowledge their lived experience. If they say “I had flu and was fine,” validate that while noting outcomes vary widely. The influenza virus is different to the common cold and can have more severe consequences — many people still die from flu. During the 2024–2025 season in England, there were 53 deaths associated with influenza in those aged under 18. During winter, the NHS comes under a lot of additional strain as more people become unwell — protecting your child from flu early can help ensure they don’t get seriously ill, and relieve winter pressures on local healthcare systems for everyone.
  • Reframe vaccination as a protective choice, not a rejection of natural immunity: “The vaccine gives the immune system a safe practice run.”
Worries about side effects & stories from others

“I’ve heard worrying stories and I don’t know what to believe”

A parent is contacted to complete an outstanding consent form for HPV immunisation. They feel anxious after hearing stories from friends, family and social media about children experiencing side effects. They are not against vaccination but are worried about possible reactions and long-term effects.

“I’ve heard stories about children becoming unwell after vaccines and it’s made me nervous.” “I’ve seen things online about serious side effects.” “I’m worried there could be long-term effects we don’t know about yet.” “I’m not anti-vaccine — I’m just scared something might happen to my child.”

Comments from our workshop

  • Signpost people to information on the frequency of side effects.
  • Manage expectations: mild side effects are quite common but tend to disappear quickly. Severe side effects are very rare (1.7 in 1 million — WHO) — far less likely than the risks from cervical or other related cancers.
  • Experiencing side effects, such as tiredness, shows that the vaccine and your immune system are working to protect you.
  • Tell children and parents what to expect, so mild side effects are recognised and treated at home, usually with paracetamol, rather than prompting panic or a trip to A&E.
  • Mild side effects such as fever can be seen as encouraging signs — they show the immune system has responded and is developing protection.
Worries that the vaccine is “new”

“How do we know it’s safe if it’s new?”

A parent contacts the school immunisation team after receiving information about an upcoming vaccine. They have never heard of it and feel unsure because it seems “new,” worrying there hasn’t been enough time to know whether it’s safe or necessary.

“I’ve never even heard of this vaccine before.” “It feels like it’s suddenly appeared.” “How do we know it’s safe if it’s new?” “I’d rather wait a few years until we know more.”

Comments from our workshop

A nurse in a consultation with a parent holding a toddler, pointing to a ‘Routine Immunisation’ chart on the wall that runs from baby to toddler to teenager to healthy adult, with the teenage stage circled.
  • Acknowledge the uncertainty first: “It makes sense to have questions about something you haven’t heard of before.” Reassure them that many parents feel unsure when a vaccine is new to them, even if it has been studied for years.
  • Clarify what “new” actually means — that vaccines go through extensive testing and monitoring before being offered, and continue to be monitored once in use. For example, in the UK, the HPV vaccine has been offered to girls since 2008 and boys since 2019, and before being registered for use, HPV vaccines go through years of testing in clinical trials.
  • Be transparent about what is known and how safety is checked: clinical trials, ongoing surveillance, and how side effects are tracked.
  • Avoid overwhelming them with technical detail. Keep explanations short, clear and focused on their child.
  • Address the “wait a few years” concern gently: delaying leaves children unprotected during the years the vaccine is recommended and most effective. Vaccines are given when children’s immune systems are most responsive, to maximise effectiveness, and before the vast majority of children are likely to be exposed to infection.
  • Invite specific questions: “What part of being vaccinated feels most uncertain to you?” This moves from general worry to a concrete conversation.
  • Avoid dismissing their worry as misinformation. Instead, offer to look at information together or provide trusted sources.
  • Reassure them they are not being rushed — your role is to support informed decision-making, not to pressure them.
  • Some secondary school-age vaccines may appear new simply because parents haven’t heard of them — often because they’re delivered at school rather than by the GP, and aren’t recorded in the “red book.” Awareness is lower as a result, but that’s improving: there are several secondary school-age vaccinations beyond the flu vaccine, and they’re all important, effective and safe.
Distrust in vaccines & healthcare guidance

“I just don’t trust vaccines”

A parent explains they do not trust vaccines in general. Their concerns are broad — shaped by things seen online, stories from friends and family, and a recent A&E experience where a nurse reportedly said there was “no need” to vaccinate. Their worries centre on safety, transparency and trust in healthcare organisations.

“I just don’t trust vaccines.” “There’s too much conflicting information.” “I think we’re not being told everything.” “Pharmaceutical companies make money from vaccines.” “I don’t trust the government or health organisations anymore.” “A health professional even told me not to vaccinate.”

Comments from our workshop

  • Acknowledge the emotion before the content: “It sounds like there’s been a lot of conflicting information, and that can feel overwhelming.”
  • Avoid arguing with the distrust — direct contradiction can deepen resistance. Start with understanding, not correction.
  • Validate that it’s reasonable to have questions and uncertainty: “Lots of parents feel unsure when they hear different things.”
  • Ask open, curiosity-based questions to identify the specific concern behind the general distrust: “What have you heard that worries you most?”
  • Gently separate sources of information. Acknowledge that online content varies in quality, and offer to look at concerns together rather than dismissing them.
  • Use clear, transparent explanations and emphasise what is known about safety and effectiveness.
  • Highlight shared goals to re-establish partnership rather than opposition: “We both want your child to be safe and healthy.”
  • Offer small, manageable next steps — written information, an invitation to return with more questions, or a follow-up conversation.
Feeling dismissed when raising concerns

“I want someone to take my concerns seriously”

A parent is contacted to complete a consent form for her daughter. Several years ago, after her son developed swelling and hives following an MMR vaccine, her GP dismissed the possibility of an allergic reaction. Since that experience she has felt unsure who to approach and has delayed completing the form.

“I want someone to take my concerns seriously, not sigh or roll their eyes.” “I have questions but I don’t want to sound gullible or stupid.” “I don’t want to be judged or seen as a ‘difficult parent’.”

Comments from our workshop

  • Acknowledge the past experience: “I’m sorry you felt dismissed before — that shouldn’t have happened.” Validating the feeling matters more than debating the clinical details.
  • Reassure them that questions are expected, welcome and part of informed consent. They are not being “difficult” by wanting clarity.
  • Avoid minimising or correcting too quickly — jumping straight to reassurance can feel like another dismissal. Start with empathy before offering information.
  • Use simple, non-judgemental language. Avoid jargon or overly technical phrasing.
  • Outline how concerns can be followed up in future (e.g. school nurse, GP, immunisation team).
Conversation skills

Practical tips for constructive conversations

Frameworks and techniques to help vaccine conversations go well — involving listening, building trust and responding to concerns without confrontation.

The 5 Rs

  • Respect for one another
  • Relate to a shared identity
  • Reframe our arguments to address others’ concerns
  • Revise our questions
  • Repeat all of the above

‘Empathy not endorsement.’ Strategies aren’t meant to change someone’s mind, but to increase the chance of other perspectives being heard. There are limits to changing minds.

WHO: how to talk about vaccines

  • Listen with empathy and acknowledge how the other person is feeling — parents can feel judged when talking with healthcare professionals.
  • Ask open-ended questions: “What have you heard about X vaccine?”, “Why do you feel that way?”
  • Share trusted information, and offer to help look for it — asking permission first can make people more willing to listen.
  • Explore reasons for wanting to get vaccinated — share motivations.

Learning from SENCOs (Special Educational Needs Coordinators): handling difficult conversations with parents

  • Start with a positive. Mention a strength to set a good tone before the harder topic — for example, “It’s clear you care deeply about your child’s health and wellbeing, and that’s a real strength as we talk through this.”
  • Use clear, calm language. Be direct and honest, but non-judgemental and compassionate.
  • Listen actively. Give them space to speak; use phrases like “I can see why you’re concerned” to show you understand without necessarily agreeing.
  • Keep it focused on your shared goal, and gently guide it back if it goes off-topic.

Talking directly to children about HPV and immunisation

  • Lead with health, not fear.
  • Explain what HPV is, keeping it simple and factual.
  • Talk about the vaccine as routine care.
  • Encourage questions, and be honest.

“Does it hurt?” — Like any injection, there might be some brief discomfort, during or after it’s given. However, the short-term pain is worth it for the long-term benefit of protecting your health and preventing cancer in the future.

Share stories, not just science

Personal stories of real people can strike a chord and help people see the benefits of vaccination in a relatable way. These could be examples from your own experience:

“I was nervous about getting my child vaccinated too, but seeing the devastation the disease itself can cause helped me make up my mind.”

…or from reputable news sources, e.g. Alexandra Legg on BBC News, treated for cervical cancer and now a real advocate for the HPV vaccine.

Tips from our working group

  • If someone shares misinformation (e.g. “natural immunity is better”), gently ask a bit more — where did they hear or read that?
  • Acknowledge it’s really difficult to manage all the different sources of information.
  • These thoughts won’t have just materialised — they come from somewhere, such as cultural background or growing up with vaccine scepticism.
  • Explore their ideas, concerns and expectations. There’s no point giving facts without listening to their point of view.

UCL Disagreeing Well resources are especially helpful for conversations with people who are sceptical about vaccines:

TEDx talk: how to unpolarise our relationships · 10 ways to have a better conversation · Disagreeing Well skills video series. A key idea: “Listen with the intent to understand, not with the intent to reply” — and try reflecting back, repeating even a single word someone has said to show you’re listening and help keep the conversation calm.

Stay sharp online

Spotting misinformation & disinformation

Tips to share on identifying misleading vaccine content — what to watch for, how to verify it, and how to evaluate a source.

A worried young person scrolling alarming social media posts — ‘this is bad’, ‘it’s not real’, ‘no way’ — next to trusted sources: ask your pharmacy, read all the facts, the immunisation team will have the answers.
Alarming posts are designed to provoke a reaction — pause, and check with trusted sources like your pharmacy or immunisation team.
1

Watch for common tactics

Emotional appeals. Posts that heavily rely on fear, anger or tragic anecdotes rather than clinical data.
“Fake” experts. Individuals portrayed as experts who lack relevant qualifications or job roles.
Cherry-picked data. Numbers used in misleading ways — tiny or outdated studies, ignoring the strong, consistent evidence from research worldwide.
Conspiracy theories. Claims that governments, scientists or pharmaceutical companies are secretly doing harm.
Impossible expectations. Claims that vaccines don’t work because they aren’t 100% effective with zero risk — but no medical treatment works perfectly every time.
Train yourself. Learn to spot misinformation in a fun way with Cranky Uncle Vaccine, a free digital game. Read more about it here.
2

Verify with trusted sources

Three panels: a woman checking the facts on an NHS website, then talking with a pharmacist, then taking a leaflet from a health information board.

When you encounter a suspicious claim, cross-reference it with official public health authorities and scientific databases:

3

Evaluate the source

Before sharing or believing information online, ask yourself:

  • Is the author, website or organisation transparent about their funding and methods?
  • Does the content refer to peer-reviewed research, or does it only link to other social media posts or opinion blogs?
  • Is the information up-to-date and based on the best current evidence?
Go deeper

Useful resources

Trusted organisations and materials for further information on HPV and vaccination. Parents and children may prefer some sources over others — more global, or more UK or regionally focused.

University of Bristol — hpvinform.com

Great information on what HPV is, how the vaccine protects young people and tips on getting it at school — from a leading UK university, including a “what to expect” video.

UKHSA visual vaccine guide

A useful visual summary of the vaccines used in the routine immunisation schedule.

Northern Ireland HSC Public Health Agency

HPV fact sheet aimed at healthcare professionals.

UKHSA easy-read HPV guide

An easy-to-read guide to HPV vaccination.

UKHSA myth-busting factsheet

A myth-busting factsheet aimed at healthcare professionals.

British Society for Immunology

Top tips for engaging with the public about vaccines.

Vaccination UK webinar

HPV vaccination FAQs and myth-busting (video).

NHS: why vaccination is important

Includes a video of a GP reassuring a parent about vaccinations for her young child.

Vaccination UK HPV webinar, May 2026

The most recent webinar in the series (video).

Greater Manchester Integrated Care Partnership

Busting childhood vaccine myths.

Building Vaccine Confidence with Dr Nikita Kanani

A series of videos led by Dr Kanani on how to challenge misinformation and talk with parents and teenagers. Produced by MSD, the HPV vaccine manufacturer, for healthcare professionals.

Printable: NHS HPV poster

A print-ready NHS “HPV for all” poster for community, healthcare and education settings.

International HPV Awareness Campaign

Campaign resources from the International Papillomavirus Society — videos, fact sheets, and a podcast series on vaccine hesitancy, tailored to young people, parents and carers, and healthcare professionals.

Reputable organisations for vaccine information: GOV.UK / UKHSA · Vaccination UK (commissioned by NHS England since 2015 to deliver school-aged immunisation programmes) · NHS Vaccinations (general information about all the vaccines you can get across the lifespan) · World Health Organization · GAVI, the Global Vaccine Alliance — whose HPV vaccine guide has an international focus, particularly relevant for lower- and middle-income countries. This is not an exhaustive list, but a good place to start.

Reaching every community

Community resources

The NHS provides HPV guidance leaflets, posters and more, translated into 33 languages — including Albanian, Arabic, Bengali, Brazilian Portuguese, Bulgarian, Chinese, Estonian, Fijian, Farsi, Greek, Gujarati, Hindi, Kurdish Sorani, Latvian, Lithuanian, Nepali, Pashto, Panjabi, Polish, Romanian, Romany, Russian, Somali, Spanish, Tagalog, Turkish, Tigrinya, Twi, Ukrainian, Urdu, Yiddish and Yoruba. It is also available as a BSL video to download and in easy-read versions.

Involving young people

Conversations with kids

Young people have the right to be involved in decisions about their own health. This section covers their decision-making rights and ability to consent for themselves, how Gillick competence works in practice, managing needle anxiety, and resources aimed directly at teenagers.

Teenagers have the right to be involved in decisions about their own health. Under Gillick competence principles, a young person under 16 can consent to treatment themselves if they have sufficient understanding to make an informed decision — this applies to vaccinations too.

In practice this means:

  • Explaining what the vaccine is, why it’s offered and what to expect, in language that makes sense to a teenager, not just their parent.
  • Giving young people space to ask their own questions, separate from their parents if needed.
  • A parent’s view doesn’t automatically outweigh a young person’s, and vice versa.

How schools apply Gillick competence. Awareness and use of Gillick competence varies across the UK. Some schools and immunisation teams apply it routinely and confidently, while others are less familiar with the guidance or unsure how to put it into practice. This can lead to patchy experiences for young people, with some being fully involved in decisions about their vaccination and others not. If you’re unsure how it is handled in your area, it’s worth asking your school or local immunisation team about their policy.

Further reading: NSPCC Gillick competence guidance; NHS consent to treatment – children.

There is no set list of defined questions to assess Gillick competence. Professionals need to consider several things when assessing a child’s capacity to consent, including:

  • the child’s age, maturity and mental capacity;
  • their understanding of the issue and what it involves — including advantages, disadvantages and potential long-term impact;
  • their understanding of the risks, implications and consequences that may arise from their decision;
  • how well they understand any advice or information they have been given;
  • their understanding of any alternative options, if available;
  • their ability to explain a rationale around their reasoning and decision-making.

Remember that consent is not valid if a young person is being pressured or influenced by someone else.

A queue of pupils along a school corridor waiting outside the vaccination room; the boy at the back holds his stomach anxiously while a nurse’s silhouette holds up a syringe in the doorway. The vaccination itself: a nurse rests a reassuring hand on a seated pupil’s shoulder, a plaster already on his arm, a clock showing how quickly it was over.

Fear of needles is one of the most common reasons young people decline vaccinations — and one of the most manageable. The goal is to normalise, rationalise and equip young people with practical techniques before and during the appointment.

Before the vaccination:

  • Acknowledge the fear without dismissing it — “lots of people feel this way” reduces shame.
  • Explain what will actually happen, step by step. Uncertainty often amplifies anxiety.
  • Encourage young people to flag their anxiety to the nurse in advance.

During the vaccination:

  • Relaxation techniques: slow breathing, distraction (music, conversation), muscle tensing and releasing.
  • Positioning: sitting rather than lying, looking away if preferred.
  • Keep the atmosphere calm — nurses setting a confident, reassuring tone makes a significant difference.

After the vaccination:

  • Acknowledge and normalise any physical reaction (brief sting, light-headedness).
  • Offer a sincere, age-appropriate acknowledgement of their effort — for example, “You handled that really well.”

Alternative settings. Many school-age immunisation teams can offer vaccinations outside the school environment — for example at a community clinic or a different time of day. For some young people, being vaccinated away from peers or busy school settings can significantly reduce anxiety. If you think this might help, talk to your local immunisation team about what alternatives are available.

Further reading: Guy’s and St Thomas’ needle phobia guide; Great Ormond Street Hospital: Nervous About Needles; NHS top tips poster (before, during and after).

Who made this

Project team

This toolkit was co-developed by a team of public health researchers, clinical leads and a conflict mediator, drawing on the UCL Disagreeing Well programme.

Dr Becky Baggaley

Dr Becky Baggaley

Researcher

UCL

Profile
Priyanka Chaudhuri

Priyanka Chaudhuri

Researcher

UCL

Profile
Christina Mannion

Christina Mannion

Clinical Lead

Vaccination UK

Jacqueline Price

Jacqueline Price

Clinical Lead

Vaccination UK

Dr Luisa Silva

Dr Luisa Silva

GP, Researcher

University of Leicester

Mia Forbes Pirie

Mia Forbes Pirie

Conflict Mediator and Coach